STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 79 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $274,000 | +114.1% | 99,397 | +89.0% | 0.09% | +137.8% |
Q4 2020 | $128,000 | +106.5% | 52,597 | +77.3% | 0.04% | +85.0% |
Q3 2020 | $62,000 | +44.2% | 29,667 | +162.8% | 0.02% | +33.3% |
Q2 2020 | $43,000 | -2.3% | 11,287 | -51.5% | 0.02% | -21.1% |
Q1 2020 | $44,000 | – | 23,257 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 978,907 | $6,865,000 | 3.28% |
RA Capital Management | 2,690,702 | $20,449,000 | 2.02% |
NEA Management Company, LLC | 2,141,308 | $16,274,000 | 1.04% |
Broadfin Capital, LLC | 1,656,705 | $10,911,000 | 0.67% |
Tredje AP-fonden | 909,581 | $6,913,000 | 0.44% |
Granite Point Capital Management, L.P. | 388,945 | $2,679,000 | 0.40% |
Ghost Tree Capital, LLC | 72,726 | $553,000 | 0.23% |
SPHERA FUNDS MANAGEMENT LTD. | 181,818 | $1,382,000 | 0.20% |
Tower Research Capital LLC (TRC) | 1,094 | $8,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 1,373 | $10,000 | 0.00% |